Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Eton Pharmaceuticals Inc

ETON
Current price
3.6 USD -0.02 USD (-0.55%)
Last closed 3.56 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 94 936 080 USD
Yield for 12 month +15.38 %
Week
Month
Year
ETON
21.11.2021 - 28.11.2021

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and dehydrated alcohol injection to treat methanol poisoning. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis; Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis; EPRONTIA, a liquid formulation of topiramate; ZONISADE, a liquid formulation of zonisamide for the treatment of partial seizures in patients with epilepsy; and Lamotrigine for Oral Suspension for the treatment of epilepsy. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois. Address: 21925 West Field Parkway, Deer Park, IL, United States, 60010-7208

Analytics

WallStreet Target Price

10 USD

P/E ratio

41.1111

Dividend Yield

Current Year

+21 251 000 USD

Last Year

+21 832 000 USD

Current Quarter

+7 028 000 USD

Last Quarter

+11 997 000 USD

Current Year

+14 318 000 USD

Last Year

+19 209 000 USD

Current Quarter

+4 403 000 USD

Last Quarter

+9 682 000 USD

Key Figures ETON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 2 671 000 USD
Operating Margin TTM -7.8 %
PE Ratio 41.1111
Return On Assets TTM 4.39 %
PEG Ratio
Return On Equity TTM 15.9 %
Wall Street Target Price 10 USD
Revenue TTM 32 827 000 USD
Book Value 0.66 USD
Revenue Per Share TTM 1.29 USD
Dividend Share
Quarterly Revenue Growth YOY 118.3 %
Dividend Yield
Gross Profit TTM 14 318 000 USD
Earnings Share 0.09 USD
Diluted Eps TTM 0.09 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -12.6 %
Profit Margin 6.8 %

Dividend Analytics ETON

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ETON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ETON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 41.1111
Forward PE 14.3885
Enterprise Value Revenue 2.4271
Price Sales TTM 2.892
Enterprise Value EBITDA 22.5003
Price Book MRQ 5.6809

Financials ETON

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ETON

For 52 weeks

2.42 USD 5.81 USD
50 Day MA 3.99 USD
Shares Short Prior Month 954 596
200 Day MA 3.82 USD
Short Ratio 9.29
Shares Short 753 553
Short Percent 3.1 %